124 related articles for article (PubMed ID: 33896439)
1. Relationship between dietary macronutrient composition and non-alcoholic fatty liver disease in lean and non-lean populations: a cross-sectional study.
Amirkalali B; Khoonsari M; Sohrabi MR; Ajdarkosh H; Motamed N; Maadi M; Nobakht H; Gholizadeh E; Zamani F
Public Health Nutr; 2021 Dec; 24(18):6178-6190. PubMed ID: 33896439
[TBL] [Abstract][Full Text] [Related]
2. Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study.
Alferink LJ; Kiefte-de Jong JC; Erler NS; Veldt BJ; Schoufour JD; de Knegt RJ; Ikram MA; Metselaar HJ; Janssen H; Franco OH; Darwish Murad S
Gut; 2019 Jun; 68(6):1088-1098. PubMed ID: 30064987
[TBL] [Abstract][Full Text] [Related]
3. Associations of Macronutrients Intake With MRI-determined Hepatic Fat Content, Hepatic Fibroinflammation, and NAFLD.
Chen S; Pang J; Huang R; You Y; Zhang H; Xue H; Chen X
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1660-e1669. PubMed ID: 37290038
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
[TBL] [Abstract][Full Text] [Related]
5. Low physical activity and energy dense Malaysian foods are associated with non-alcoholic fatty liver disease in centrally obese but not in non-centrally obese patients with diabetes mellitus.
Chan WK; Tan AT; Vethakkan SR; Tah PC; Vijayananthan A; Goh KL
Asia Pac J Clin Nutr; 2015; 24(2):289-98. PubMed ID: 26078246
[TBL] [Abstract][Full Text] [Related]
6. Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.
Li C; Guo P; Okekunle AP; Ji X; Huang M; Qi J; Jiang Y; Feng R; Li R
J Gastroenterol Hepatol; 2019 Jan; 34(1):256-262. PubMed ID: 29949199
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
[TBL] [Abstract][Full Text] [Related]
8. Macronutrient and Micronutrient Intake in Adolescents With Non-alcoholic Fatty Liver Disease: The Association With Disease Severity.
Porto A; Pan Z; Zhou W; Sokol RJ; Klaczkiewicz K; Sundaram SS
J Pediatr Gastroenterol Nutr; 2022 Nov; 75(5):666-674. PubMed ID: 35897136
[TBL] [Abstract][Full Text] [Related]
9. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
Chen N; Zhou J; Wang K; Li X; Li Z
BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
[TBL] [Abstract][Full Text] [Related]
10. Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka.
Niriella MA; Kasturiratne A; Pathmeswaran A; De Silva ST; Perera KR; Subasinghe SKCE; Kodisinghe SK; Piyaratna TACL; Vithiya K; Dassanayaka AS; De Silva AP; Wickramasinghe AR; Takeuchi F; Kato N; de Silva HJ
Hepatol Int; 2019 May; 13(3):314-322. PubMed ID: 30539516
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study.
Semmler G; Wernly S; Bachmayer S; Wernly B; Schwenoha L; Huber-Schönauer U; Stickel F; Niederseer D; Aigner E; Datz C
Clin Transl Gastroenterol; 2021 Apr; 12(4):e00326. PubMed ID: 33821832
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance.
Lu CW; Yang KC; Chi YC; Wu TY; Chiang CH; Chang HH; Huang KC; Yang WS
Ann Med; 2023 Dec; 55(1):634-642. PubMed ID: 36790383
[TBL] [Abstract][Full Text] [Related]
13. Dietary sodium and potassium intake in relation to non-alcoholic fatty liver disease.
Choi Y; Lee JE; Chang Y; Kim MK; Sung E; Shin H; Ryu S
Br J Nutr; 2016 Oct; 116(8):1447-1456. PubMed ID: 27725000
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
Chakrabarty M; Jha AN; Sharma DJ
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
[TBL] [Abstract][Full Text] [Related]
15. Positive Association Between the Chinese Visceral Adiposity Index and Nonalcoholic Fatty Liver Disease in Lean Adults.
Shen S; Huang H; Wang J; Tang Z; Shen C; Xu C
Dig Dis Sci; 2023 Feb; 68(2):656-664. PubMed ID: 36512267
[TBL] [Abstract][Full Text] [Related]
16. Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study.
Wang Q; Shi X; Wang J; Zhang J; Xu C
Nutr J; 2021 Apr; 20(1):30. PubMed ID: 33794916
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population.
Li MR; Li JZ; Li JY; Wang CC; Yuan RK; Ye LH; Liu YY; Liang XJ; Zhang HC; Liu ZQ; Zeng DY; Zhang XD; Wang DH; Li JQ; Li TY; Yang L; Cao Y; Pan Y; Lin XG; Pan CQ; Dai EH; Dong ZY
Obes Facts; 2023; 16(5):427-434. PubMed ID: 37231905
[TBL] [Abstract][Full Text] [Related]
18. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
19. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
Younes R; Govaere O; Petta S; Miele L; Tiniakos D; Burt A; David E; Vecchio FM; Maggioni M; Cabibi D; McLeod D; Pareja MJ; Fracanzani AL; Aller R; Rosso C; Ampuero J; Gallego-Durán R; Armandi A; Caviglia GP; Zaki MYW; Liguori A; Francione P; Pennisi G; Grieco A; Birolo G; Fariselli P; Eslam M; Valenti L; George J; Romero-Gómez M; Anstee QM; Bugianesi E
Gut; 2022 Feb; 71(2):382-390. PubMed ID: 33541866
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
